OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.42 Cr | - | ₹-0.01 Cr | ₹-0.05 Cr | ₹-0.29 Cr |
What is the latest Net Cash Inflow / Outflow ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹0.42 Cr |
| Mar2025 | - |
| Mar2024 | ₹-0.01 Cr |
| Mar2023 | ₹-0.05 Cr |
| Mar2022 | ₹-0.29 Cr |
How is Net Cash Inflow / Outflow of OXYGENTA PHARMACEUTICAL Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.42 Cr | 0 | |
| Mar2025 | - | 100.00 | |
| Mar2024 | ₹-0.01 Cr | Negative | |
| Mar2023 | ₹-0.05 Cr | Negative | |
| Mar2022 | ₹-0.29 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹200.5 Cr | -3.4% | 4.6% | -24.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3.4% |
4.6% |
-24.2% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses